Phyllis A. Gimotty

About

Phyllis A. Gimotty is a distinguished biostatistician whose work bridges quantitative rigor and clinical impact, particularly in oncology and head and neck cancer research. Her key contributions center on developing predictive models for recurrence and survival in human papillomavirus (HPV)-related oropharyngeal cancers, especially following transoral robotic surgery (TORS). In her highly cited 2022 benchmark study, she established a model for lethal recurrence risk after TORS, providing clinicians with a validated tool to stratify patients by risk—a critical advance given the rising use of robotic surgery for HPV-positive head and neck squamous cell carcinomas. Her earlier work (2021) profiled recurrence patterns and identified features predictive of lethal outcomes, offering early insights into how TORS alters disease trajectories. With over 16 citations on her landmark paper alone, Gimotty’s research has shaped surgical oncology decision-making, helping to refine treatment de-escalation strategies and improve prognostic accuracy. Her methodological contributions exemplify how biostatistical modeling can directly enhance patient care, making her a pivotal figure in the evolution of precision oncology for HPV-related cancers.

Research Focus

Key Achievements

Top Papers

1. 1
   A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers

   16 citations · 2022
2. 2
   Outcomes and prediction of lethal recurrence after transoral robotic surgery for HPV+ head and neck cancer.

   2 citations · 2021

Key Collaborators

Contact & Links